The combined stack for Indian IVF clinics: PrismSpy plus Meta Catalyst IQ, and why running IVF Meta ads without both is why CPL stays stuck at ₹1,800+

IVF is the specialty where Meta ads are the most competitive, the most compliance-sensitive, and the most likely to bleed budget without a diagnostic. Cost per qualified lead in Indian IVF marketing typically sits in the ₹1,200 to ₹2,200 range across the top quartile of accounts, and above ₹3,000 for accounts running Meta blind. The ICG portfolio across 11 tracked IVF clients averages ₹632 CPL against ₹2.6Cr of monthly Meta spend, which is not the result of superior media buying alone. It is the result of running PrismSpy as the daily intelligence layer against 30+ tracked IVF competitors, and Meta Catalyst IQ as the daily decision layer inside every account. This post walks through the IVF-specific version of that combined stack — what the morning scan surfaces in an IVF cluster, what the midday review typically catches, how the ART Act and PC-PNDT compliance perimeter reshapes both layers, and the 90-day path a typical IVF clinic runs to move CPL from ₹1,800+ into portfolio-benchmark range.

Why IVF is the hardest Meta ads specialty in Indian healthcare

Three factors compound. First, the consideration cycle. An IVF patient in India typically takes 6 to 12 months from first fertility concern to first cycle booking. That means every ad you show has to sit through months of comparison shopping before it converts, and lead attribution over that window is genuinely difficult. Second, the compliance perimeter. The ART (Regulation) Act 2021 prohibits unsubstantiated success-rate claims. PC-PNDT Act 1994 hard-stops any content adjacent to sex selection. NMC Ethics Code 2026 restricts individual physician promotion. Every single ad has to sit inside those constraints, which strips out the strongest hooks used in less regulated specialties. Third, the emotional intensity. IVF decisions are private, slow, and researched deeply — meaning surface-level ads that work in aesthetics or dental do not work here.

The consequence is that IVF Meta ads look deceptively similar across competitors — free consultation, doctor-forward creative, cycle process explainer, patient story with heavy consent framing — but the small differences in offer structure, hook language, and creative production quality account for the majority of the CPL spread between top-quartile ₹650 and bottom-quartile ₹3,000+ accounts. Those small differences are exactly what PrismSpy catalogues and Meta Catalyst IQ diagnoses.

What the IVF morning PrismSpy scan actually surfaces

The IVF Watchlist in PrismSpy tracks 30 to 45 competitors depending on the city clusters the client wants covered — Delhi NCR, Mumbai, Bangalore, Hyderabad, Chennai, Pune, and Ahmedabad typically account for the top 30, with regional players filling the rest. On a normal morning the Activity Feed will show three to six events per day across the cluster. On a heavy morning — usually the first week of a month when brands relaunch budgets, or the week around Mother's Day, Doctor's Day, and the pre-Diwali fertility campaign window — it will show fifteen to twenty.

The events that matter are new offers, killed ads (a competitor turning off a long-running creative usually means the offer stopped converting for them and you should not clone it), and spend spikes. A competitor whose spend rose 40 to 60 percent overnight is either running a launch campaign for a new procedure (e.g. donor-cycle package, PGT-A add-on) or is buying share ahead of a specific referral peak. Either way, your own audience frequency in the shared audience pool will feel it within 5 to 7 days.

Comparative Insights for the IVF cluster consistently shows the same pattern year over year — the Longest-Running creatives are almost always doctor-led explainer videos in the 45 to 90 second range, with a single specific piece of clinical education (AMH interpretation, IVF cycle length demystification, second-opinion policy) rather than a broad "we do IVF" pitch. Emerging Offers in Indian IVF drift on a 4 to 6 week cycle — free AMH testing, ₹0 first consultation, EMI for the full cycle, package pricing for combined IVF-plus-ICSI, second-opinion warranty on failed cycles.

What the IVF midday Meta Catalyst IQ review catches

The midday review in an IVF account looks slightly different from other specialties because the leads take longer to qualify. Cost per raw lead can look attractive, but cost per qualified lead — a lead where the couple actually books a consult and shows up — is the metric that matters. Meta Catalyst IQ's CPQL engine handles this by tracking the lead through Beacon (ICG's Meta CAPI attribution engine) all the way to consult booking, then back-attributing the qualification signal to the ad-set level.

The 2-Day Comparative on an IVF account typically flags three recurring issues. Naming Intelligence catches ad sets that were named inconsistently between "IVF" and "Fertility" or between "Delhi" and "Delhi NCR" — which sounds trivial but breaks Lead Source rollup and makes CPQL invisible to the media buyer. Creative Scoring surfaces ads that look great on hook rate but collapse on hold rate at the 15-second mark, which in IVF creative is almost always because the ad opens with an emotional hook and fails to earn the extended attention with clinical substance.

Money Wastage on IVF accounts tends to concentrate in three categories: over-targeted lookalike audiences that are too narrow to exit Learning Phase, city-specific ad sets that were left running after city budgets consolidated, and creative variants that never got killed after their sibling scaled. A typical monthly Money Wastage Cleanup on an IVF account recovers ₹40,000 to ₹1,20,000 depending on account size.

The two-tool loop: intel → execution → intel

The reason single-tool Meta ads programmes plateau is that intelligence and execution live in separate rhythms. Weekly competitor scan by a strategist. Daily campaign management by a media buyer. They never fully close the loop. PrismSpy + Meta Catalyst IQ compress that into one daily rhythm inside ICG:

1. Morning (PrismSpy) — scan overnight changes across the specialty watchlist. New offers, killed ads, spend spikes.
2. Midday (Meta Catalyst IQ) — 2-Day Comparative + Money Wastage review. What in our own account moved, and why?
3. Afternoon (loop) — creative brief for tomorrow's ads uses PrismSpy's Inspirations swipe file (what's working in-category) plus Catalyst's Creative Scoring (what's working for us specifically).

The output isn't more reports. It's fewer wasted rupees. ICG portfolio average: 30–50% of pre-optimisation Meta spend was waste; post-optimisation it drops to 5–12%.

The IVF-specific compliance perimeter both tools enforce

The ART Act 2021, PC-PNDT Act 1994, NMC Ethics Code 2026, ASCI Guidelines 2022, and DPDP Act 2023 all apply to every IVF ad in India. In practice, four things are almost always what gets an IVF ad flagged or complained-against: (1) unsubstantiated success rate claims — "highest success rate in Delhi", "80% success rate", (2) fear-based framing — "your fertility window is closing", (3) any content that could be interpreted as sex-selective, and (4) patient identifying content without documented consent.

PrismSpy's value here is comparative. When a competitor runs a claim like "highest success rate in the region," you can see it, benchmark your own conservatism against actual market practice, and either flag it to ASCI (which several ICG clients have done) or use it as evidence when a client asks why we cannot run a similar claim. Meta Catalyst IQ's value is preventive — the Hygiene Factors checklist flags any ad-set copy that contains claim language pattern-matched against the ART Act prohibitions, and Naming Intelligence separates funnel segments so a compliance-sensitive campaign never bleeds into a generic-brand campaign.

The joint effect is that IVF clients running the combined stack have never had an ASCI action against them or an ART Act inquiry in the four years ICG has been running IVF Meta ads. That is not an accident. It is the direct consequence of both surfaces enforcing the same perimeter every day.

The CPQL not CPL shift that changes IVF media buying

The single most important shift in an IVF Meta ads programme is moving from CPL (cost per raw lead) to CPQL (cost per qualified lead). An IVF raw lead is a form fill. An IVF qualified lead is a couple that (1) has a genuine fertility concern, (2) is in the geographic catchment of the clinic, (3) has the financial capacity for IVF (usually validated by income question or by the clinic's intake team), and (4) is in the consideration window rather than casually researching.

The gap between CPL and CPQL is bigger in IVF than in almost any other specialty. A ₹600 CPL account can have a ₹2,800 CPQL if lead quality is poor. A ₹1,200 CPL account can have a ₹1,600 CPQL if lead quality is high. The CPQL engine in Meta Catalyst IQ handles this by pulling the qualified-lead signal from the clinic's intake CRM (through Beacon's Meta CAPI pipeline) and attributing it back to the ad-set that produced the lead.

Once the account is scored on CPQL rather than CPL, the decisions change. Ad sets targeting the wrong income tier get killed even if their CPL is low. Ad sets targeting the right qualified audience get scaled even if their CPL is high. Creative that produces raw leads but not qualified leads gets replaced. The interactive CPQL calculator is where most new IVF clients first see the gap between their reported CPL and their real CPQL.

The 90-day path from ₹1,800 CPL to portfolio-benchmark range

The 90-day CPL reduction path in IVF follows a predictable arc. Weeks one and two are hygiene — Naming Intelligence surfaces on average 8 to 14 naming conflicts per new IVF account, most of them city-cluster or service-cluster mislabels. Beacon gets installed to recover Meta CAPI attribution signal, which usually adds back 30 to 45 percent of the qualified-lead signal that iOS14 and third-party cookie deprecation had cost the account. The Hygiene Factors checklist runs and typically finds two to four failing checks (broken pixel events, unsynced Custom Audiences, expired Lookalikes).

Weeks three through five are creative diagnosis. Creative Scoring Matrix separates the account's ads into Core Performer, Scalable, Getting Started, and Review. The Review-zone ads get killed. The Getting Started ads are left to complete Meta's Learning Phase. The Scalable ads get budget-shifted from the Review ads that were killed. The Core Performer ads become the pattern signature the next creative brief is written against.

Weeks six through nine are competitive alignment. PrismSpy's Inspirations swipe file for the IVF cluster gets systematically reviewed. Hook lines the client is not using but that have long-running proven performance across three or more cluster competitors get shortlisted. Offer structures the client has not tested but that have appeared in Emerging Offers for two consecutive weeks get built into brief hypotheses. The next creative production cycle produces four to six ads written directly against those hypotheses.

Weeks ten through twelve are compounding. CPQL by ad-set stabilises. Money Wastage Cleanup delivers the second and third months of recovered spend. CPL trajectory shows the 38 to 58 percent reduction benchmark starting to land, with the strongest accounts moving from ₹1,600 to ₹1,800 CPL into the ₹700 to ₹950 CPQL range that anchors the ICG IVF portfolio.

What changes when the clinic has multiple cities

Multi-city IVF chains — three, five, or ten centres — are where the combined stack produces its highest returns per rupee invested. PrismSpy's Watchlist can be split by city cluster, which lets each centre's marketing lead see the local competitive set rather than the aggregated national picture. Meta Catalyst IQ's Master Dashboard rolls up all city accounts into one portfolio view for the CMO, with drill-down to each city's CPQL, spend allocation, and Money Wastage independently.

The most common finding on a multi-city IVF audit is that budget allocation across cities is stale — a budget split set 12 or 18 months ago that no longer reflects current qualified-lead economics per city. The 2-Day Comparative and Long-term Comparison views surface this within the first review cycle, and the reallocation typically produces 10 to 20 percent portfolio CPQL improvement independent of any creative or hook changes.

Powered by PrismSpy — every competitor Meta ad, watched daily

ICG built PrismSpy because Indian healthcare Meta ad competition is invisible without it. 75+ Indian healthcare brands tracked, 2,150+ active ads catalogued, ₹50Cr+ aggregate ad spend visibility per month. Every competitor ad — creative, offer, hook, run-length — refreshed daily. It runs underneath every Meta ads and performance marketing engagement at ICG. The IVF cluster specifically tracks 30 to 45 fertility competitors across the major metros with cycle-length, offer, and creative-quality benchmarks calibrated to Indian IVF economics.

• Watchlist Dashboard — 30–45 IVF competitors per cluster, daily refresh, spend + creative + offer views.
• Comparative Insights — highest-quality IVF ads, longest-running creatives (proven converters), top hooks, emerging offers.
• Offers Intelligence — IVF-specific offer indexing, EMI patterns, free-consultation share, package pricing benchmarks.
• Service Cluster + Inspirations — IVF, ICSI, IUI, donor cycles, PGT-A, second-opinion, cross-tracked with hook and language patterns.

Standalone from ₹4,999/- per specialty vertical, or bundled free inside HealthApex OS (₹14,999/- flat, 9 tools). Book a 30-min PrismSpy walkthrough on WhatsApp — Rohit + Hanuman walk you through the IVF competitive landscape.

angryturtle/01-listing-overview.png" alt="Angryturtle Listing Overview — GBP watchlist with per-listing status, category, sub-scores, action count for 143+ managed Indian healthcare listings" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

Powered by Meta Catalyst IQ — the decision engine behind every Meta ad ICG runs

ICG built Meta Catalyst IQ because most Indian healthcare brands running Meta ads waste 30–50% of budget without knowing it. It's the diagnosis + decision layer above Ads Manager — Hygiene Factors 12-point checklist, Naming Intelligence (surfaces conflicts costing ₹50K–₹2L/account/month), Creative Scoring Matrix (Core Performer / Scalable / Getting Started / Review), 2-Day Comparative, SLC Framework, Money Wastage column in ₹. For IVF specifically, the CPQL engine and Beacon Meta CAPI integration are what move accounts from ₹1,800+ CPL into portfolio-benchmark range.

• Master Dashboard — 23+ accounts, ₹9.1Cr+ spend/mo optimised, ₹1,581 blended CPL vs ~₹3,200 market benchmark; IVF specifically 11 clients, ₹2.6Cr spend, ₹632 CPL.
• Diagnose → Optimise → Grow — daily hygiene checks, weekly creative scoring, monthly money wastage cleanup.
• CPQL Engine — cost per qualified lead (not just cost per lead) at ad-set level. Try the interactive CPQL calculator.
• Portfolio benchmarks — IVF ₹632, derm ₹520–1,180, dental ₹620–1,800, aesthetic ₹400–900, hospital cardiac ₹3,200.

Included free with every ICG Meta ads or Performance Marketing engagement (Starter ₹20,000/-/month tier and above). Not sold standalone. Book a free 48-hour Meta ad diagnostic or WhatsApp us.

FAQ

Is the ₹632 IVF portfolio CPL a CPL number or a CPQL number?

It is a CPQL number — cost per qualified lead where the couple has completed a first consultation. Raw CPL across the IVF portfolio is lower still, but CPQL is the metric we report because it is what maps to the clinic's actual revenue funnel.

How long before a new IVF client on the combined stack sees CPL move?

Week one to two is hygiene fixes and no visible CPL movement. Weeks three to five is when the Money Wastage Cleanup starts producing recovered spend and the Creative Scoring Matrix kills the Review zone. First meaningful CPL drop is usually visible in week four to five. Full 38 to 58 percent benchmark reduction lands around day 75 to 90.

What if we cannot run "success rate" claims — do our ads become weaker?

They become more compliant and, in the long run, better. The ART Act perimeter forces the ads to compete on genuine differentiators — physician credibility, cycle length transparency, second-opinion policies, EMI accessibility, patient support quality — rather than on unsubstantiated headline claims. Portfolio evidence is that compliant ads outperform non-compliant ads over any window longer than 6 weeks because compliant ads survive scrutiny while non-compliant ads eventually get complained-against and turned down.

Can we use PrismSpy to see what our competitors are spending on IVF Meta ads?

PrismSpy shows aggregate competitor ad spend visibility (based on Meta Ad Library's public spend ranges) with weekly and monthly rollup by brand. Absolute spend numbers per competitor are approximate — Meta reports spend in bands, not exact — but relative spend ranking and week-over-week spend changes are reliable.

Does the combined stack help with lead nurture, or only with acquisition?

The combined stack is acquisition-side. Lead nurture — the six-to-twelve month journey from first contact to cycle booking — runs on ICG's separate nurture stack (WhatsApp workflows, drip sequences, physician-led content). The two connect through Beacon, which passes qualified-lead signal from nurture back to acquisition for closed-loop attribution.

What about IVF clinics whose primary channel is referrals not paid?

The combined stack works alongside referrals rather than replacing them. Referral-driven IVF clinics use paid Meta primarily for physician credibility building and cross-city cycle acquisition, which typically runs at 20 to 40 percent of total inbound. The CPQL benchmarks are the same regardless of what share of the funnel paid represents.

Can we run this without engaging ICG for full Meta ads management?

PrismSpy is standalone-available and can be run alongside your existing IVF Meta ads team. Meta Catalyst IQ is bundled with ICG engagements only. Some IVF clinics run PrismSpy alone for competitive intelligence and continue running Meta ads in-house — that works, and it is a reasonable entry point before evaluating a fuller engagement.

Related reading

• Combined stack pillar — PrismSpy + Meta Catalyst IQ overview
• IVF clinic CPL reduction case study — 90-day walkthrough
• The Meta ads decision engine for Indian healthcare
• Combined stack for dermatology clinics
• Ad set name drift detection

Compliance references — the National Medical Commission for physician promotion rules and the Advertising Standards Council of India for advertising claim standards.